Chan Lee - GeneBioTech Chief Executive Officer, Director
| 086060 Stock | KRW 3,220 55.00 1.74% |
CEO
Lee Chan Ho is Chief Executive Officer and Director of GeneBioTechCo., Ltd. Lee also serves as Chief Executive Officer of Daone Chemical Co., Ltd. Prior to joining the Company, Lee served as Chief Executive Officer of EK INT I, President of a Koreabased trading company and Project Manager of WOOSUNG FEED CO., LTD. Lee received a Doctorate degree in Animal Science from Seoul National University, Korea.
| Age | 48 |
| Professional Marks | Ph.D |
| Phone | 82 4 1853 9961 |
| Web | https://www.genebiotech.co.kr |
Chan Lee Latest Insider Activity
Tracking and analyzing the buying and selling activities of Chan Lee against GeneBioTech stock is an integral part of due diligence when investing in GeneBioTech. Chan Lee insider activity provides valuable insight into whether GeneBioTech is net buyers or sellers over its current business cycle. Note, GeneBioTech insiders must abide by specific rules, including filing SEC forms every time they buy or sell GeneBioTech'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Chan Lee over a month ago Disposition of 1000 shares by Chan Lee of Ambarella at 77.21 subject to Rule 16b-3 | ||
Chan Lee over a month ago Disposition of 1000 shares by Chan Lee of Ambarella at 75.68 subject to Rule 16b-3 | ||
Chan Lee over a month ago Disposition of 1000 shares by Chan Lee of Ambarella at 74.12 subject to Rule 16b-3 | ||
Chan Lee over three months ago Disposition of 1202 shares by Chan Lee of BeiGene at 237.1 subject to Rule 16b-3 |
GeneBioTech Management Efficiency
The company has return on total asset (ROA) of (0.0149) % which means that it has lost $0.0149 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.7178 %, meaning that it generated $0.7178 on every $100 dollars invested by stockholders. GeneBioTech's management efficiency ratios could be used to measure how well GeneBioTech manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 3 records | CEO Age | ||
| JunHo Lee | Duksan Hi Metal | 77 | |
| Won Choi | Seoyon Topmetal Co | 57 | |
| Gyeong Yoo | Seoyon Topmetal Co | 53 | |
Management Performance
| Return On Equity | 0.72 | |||
| Return On Asset | -0.0149 |
GeneBioTech Leadership Team
Elected by the shareholders, the GeneBioTech's board of directors comprises two types of representatives: GeneBioTech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GeneBioTech. The board's role is to monitor GeneBioTech's management team and ensure that shareholders' interests are well served. GeneBioTech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GeneBioTech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Chan Lee, Chief Executive Officer, Director | ||
| Won Cho, Director | ||
| Jeong Kang, Assistant Managing Director | ||
| Yong Jeon, Non-Executive Independent Director | ||
| ChanHo Lee, Chief Director | ||
| JungSun Kang, Managing Director | ||
| Sang Choi, Internal Auditor |
GeneBioTech Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is GeneBioTech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.72 | |||
| Return On Asset | -0.0149 | |||
| Profit Margin | (0.07) % | |||
| Operating Margin | (0.03) % | |||
| Current Valuation | 41.48 B | |||
| Shares Outstanding | 8.37 M | |||
| Shares Owned By Insiders | 29.77 % | |||
| Shares Owned By Institutions | 0.56 % | |||
| Price To Earning | 19.69 X | |||
| Price To Sales | 0.63 X |
Pair Trading with GeneBioTech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if GeneBioTech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneBioTech will appreciate offsetting losses from the drop in the long position's value.Moving against GeneBioTech Stock
| 0.59 | 111770 | Youngone | PairCorr |
| 0.43 | 098460 | Koh Young Technology | PairCorr |
| 0.39 | 029780 | Samsung Card | PairCorr |
| 0.39 | 021240 | COWAY | PairCorr |
| 0.36 | 122870 | YG Entertainment | PairCorr |
The ability to find closely correlated positions to GeneBioTech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace GeneBioTech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back GeneBioTech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling GeneBioTech Co to buy it.
The correlation of GeneBioTech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as GeneBioTech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if GeneBioTech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for GeneBioTech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in GeneBioTech Stock
GeneBioTech financial ratios help investors to determine whether GeneBioTech Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GeneBioTech with respect to the benefits of owning GeneBioTech security.